NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
4.240
+0.060 (1.44%)
At close: Jul 24, 2026, 4:00 PM EDT
4.210
-0.030 (-0.71%)
After-hours: Jul 24, 2026, 7:55 PM EDT
NextCure Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, NextCure stock has a consensus rating of "Strong Buy" and an average price target of $20. The average 1-year stock price forecast is 371.70% higher than the current stock price, while the lowest is $15 (+253.77%) and the highest is $25 (+489.62%).
Price Target: $20 (+371.70%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NextCure stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $20 | Buy | Maintains | $20 | +371.70% | Jul 15, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $15 | Buy | Maintains | $15 | +253.77% | Jun 11, 2026 |
| Lucid Capital | Lucid Capital | Buy Maintains $25 | Buy | Maintains | $25 | +489.62% | Jun 2, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-7.46
from -19.65
EPS Next Year
-7.07
from -7.46
EPS and Forward PE are based on non-GAAP adjusted numbers.